• December 2003:

  CCST in Haematology

• Dec 1999 - Dec 2003:

  Internship in Haematology, National and Kapodistrian University of Athens, Laikon General Hospital of Athens Haematology Department and autologous transplant unit.

  BMT (Allogeneic Haematopoietic Stem Cell Transplant) Unit, Evangelismos General Hospital of Athens,

• Nov 1998 - Nov 1999:

  Internship in Internal Medicine, Naval and Veterans Hospital of Athens

• Nov1997-Nov1998:

  Internship in Internal Medicine, Naval and Veterans Hospital of Crete

• Oct 1996- Nov1997:

  Responsible Medical Naval Officer of War Ship Destroyer

  with the rank of Lieutenant JG of the Hellenic Navy

  Hellenic Navy

• Oct 1995 - Oct 1996:

  Rotational Internship for General Medical Practice, Naval and Veterans Hospital of Athens

• Oct 1995:

  Graduation from Military School of Medical Officers of Thessaloniki (Rank: Ensign of Hellenic Navy)

• July 1995:

  Graduation from Aristotelian University of Thessaloniki.

Specialized Training – Bone Marrow Transplantation Unit

National and Kapodistrian University of Athens (NKUA)

Cellular Therapy Unit, Department of Haematology

18 May 2025 – 18 August 2025

During this three-month specialized training, Dr. Dimitrios Boutsis received practical and theoretical training in:

1. Mobilization and collection of hematopoietic stem cells.

2. Cryopreservation and storage of hematopoietic stem cells in the cryopreservation laboratory.

3. Evaluation and selection of bone marrow donors.

4. Evaluation and selection of patients for autologous and allogeneic hematopoietic stem cell transplantation, as well as for therapies with autologous T-lymphocytes and receptor chimeric analyses.

5. Infusion of hematopoietic stem cells.

6. Procedures and management of complications related to autologous/allogeneic transplantation and CAR-T cell therapy.

7. Patient monitoring following the above procedures.

8. Standardized operating procedures relating to the above fields.

Dr. Boutsis actively and fully participated in the Unit's program, and his training was considered fully adequate for him to undertake a corresponding position.

• Sept 2022 - Present:

Director, Medical Service Corps, Hellenic Navy (Healthcare Administration, Plans, Operations, and Medical Intelligence, Medical Training, Certification and Supervision Program)

Clinical Director of Haematology Unit, Euroclinic Athens Private Hospital

Clinical Director of Haematology Unit, IASO Private General Hospital (since Feb 2023)

• Sept 2019 - Sept 2022:

Subdirector, Medical Service Corps, Hellenic Navy (Medical Training, Certification and Supervision Program)

Clinical Director of Haematology Unit, Euroclinic Athens Private Hospital

• Sept 2010 - Aug 2019:

Director, Haematology Unit, Naval and Veterans Hospital of Athens

Haematological support- consultation   in all kinds of cases needed, when hospitalised   in the Naval and    Veterans Hospital of Athens (tertiary hospital of 300beds), as well as outpatients.

Great experience in diagnosing and treating bone marrow diseases, lymphomas, multiple myeloma and thrombotic diseases, great experience in Autologous Bone Marrow Transplantation

Naval and Veterans Hospital of Athens. 70 DEINOKRATOUS STREET

• Sept 2008 - Sept 2010:

Honorary Contract in Haematology Department, Hammersmith Hospital of London, Imperial College London

• Jan 2004 - Sept 2008:

Consultant Haematologist / Lieutenant of Hellenic Navy, Naval and Veterans Hospital of Athens

• Advanced Trauma Life Support (A.T.L.S), September 24-25, 1999, National and  Kapodistrian University of Athens, Medical School.

• 3^rd Euroconference on Blood and Marrow Transplantation, November 3-7, 2001, Athens, Greece.

• 7^th ESH - EBMT Training Course on Blood and Marrow Transplantation, May 9-12, 2003, Cascais, Portugal.

• 11^th Congress of the EHA, June 15-18, 2006, Amsterdam, The Nederlands.

• Lymphoma Forum of Excellence (LyFE) Programme, September 21-22, 2006, Cologne, Germany.

• 3^rd European Congress of Haematologic Malignacies, February 23-25, 2007, Athens, Greece.

• 12^th Congress of the EHA, June 7-10, 2007, Vienna, Austria.

• 18^th Congress of the EHA, June 13-16, 2013, Stockholm, Sweden.

• 32^nd Panhellenic Society Congress, Nov 2021, Athens, Greece

• 34^th Panhellenic Society Congress, Nov 2023, Athens, Greece

  ERIC Barcelona CLL, 26-28 September 2024

1. Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.Meletis J, Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Korovesis K, Mavrogianni D, Boutsis D, Variami E, Viniou N, Konstantopoulos K, Loukopoulos D.Hematol J. 2001;2(1):33-7.

   
   

2. Vassilakopoulos T., Angelopoulou M., Siakantaris M., Kontopidou F., Dimopoulou M., Boutsis D., Anargyrou K., Kokoris S., Giannakakis A., Karkantaris C., Kyrtsonis M., Tsaftaridis P., Rombos J., Variamis E., Korkolopoulou P., Kittas C., Pangalis G.A. “Hodgkin’s lymphoma in first relapse following chemotherapy or combined modality therapy: analysis of outcome and prognostic factors after conventional salvage therapy”. Eur J Haematol 68(5):289-298, 2002.

   
   

3.  An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.Anargyrou K, Paterakis G, Boutsis D, Politou M, Papadhimitriou SI, Siakandaris M, Vassiliadis J, Androulakis A, Meletis J, Rombos J, Tassiopoulou A, Vaiopoulos G.Eur J Haematol. 2003 Oct;71(4):294-8.

   
   

4. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN,Kokoris SI, Kyrtsonis MC,Tsaftaridis P,Karkantaris C,Anargyrou K,Boutsis D, Variamis E, Michalopoulos T, Boussiotis VA, Panayiotidis P, Papavassiliou C, Pangalis GA.Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):765-81

   
   

5. Acute abdomen as initial manifestation of M4 - acute non-lymphocytic leukemia. Papalambros E, Felekouras E, Karavokyros IG, Diamantis T, Androulaki A, Boutsis D, Sigala F, Tsavaris N, Pangalis G.J BUON. 2005 Apr-Jun;10(2):277-80.

   
   

6. New oral anticoagulants: should they replace heparins and warfarin? Tsiara S, Pappas K,Boutsis D, Laffan M.Hellenic J Cardiol. 2011 Jan-Feb;52(1):52-67. Review. 

   
   

7. Bilateral metachronous testicular chloroma: a rare clinical entity.Dellis A, Boutsis D, Spyropoulos E, Galanakis I, Panagopoulos A, Papatsoris A. Nephrourol Mon. 2013 Nov;5(5):992-3

   
   

8. PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.Vassilakopoulos TP, Pangalis GA, Chatziioannou S, Papageorgiou S, Angelopoulou MK, Galani Z, Kourti G, Prassopoulos V, Leonidopoulou T, Terpos E, Dimopoulou MN, Sachanas S, Kalpadakis C, Konstantinidou P, Boutsis D, Stefanoudaki E, Kyriazopoulou L, Siakantaris MP, Kyrtsonis MC, Variami E, Kotsianidis I, Symeonidis A, Michali E, Katodritou E, Kokkini G, Tsatalas C, Papadaki H, Dimopoulos MA, Sotiropoulos V, Pappa V, Karmiris T, Meletis J, Apostolidis J, Datseris I, Panayiotidis P, Konstantopoulos K, Roussou P, Rondogianni P. Leukemia. 2016 Jan;30(1):238-42.

   
   

9. Development of Classic Hodgkin Lymhoma after successful treatment of primary mediastinal b-cell lymphoma: results from a well-defined database. Vassilakopoulos TP, Piperidou A, Hadjiharissi E, Panteliadou A, Panitsas F, Vassilopoulos I,   Variamis E, Boutsis D, Michail M, Papageorgiou S, Tsouroufis G, Dimou M, Karakatsanis S, Kalpadakis C, Stavroyianni N, Katodritou E, Kotsopoulou M, Kotsianidis I, Verigou E, Hatzimichael E, Leonidopoulou T, Xanthopoulos V, Paanayiotidis P, Konstantopoulos K, Dimopoulos M-A, Karmiris T, Batsis I, Papaioannou M, Pangalis GA, Angelopoulou MK. Leuk Res. 2021 Jan;100:106479

   
   

10. Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis. Karakatsanis S, Hellenic Cooperative Lymphoma Group, Papageorgiou S, Micail M, Angelopoulou MK, Kalpadakis C, Leonidopoulou T, Katodritou E, Kotsopoulou M, Kotsianidis I, Hatzichael E, Lakiotaki E, Boutsis D, Karianakis G, Symeonidis A, Gavriatopoulou M, Panayiotidis P, Konstantopoulos K, Karmiris T, Pangalis GA, Vassilakopoulos TP.  Leuk Res. 2021 Aug.

Announcements – Posters

1. Vassilakopoulos T., Angelopoulou M., Siakantaris M., Dimopoulou M.,   Korkolopoulou P., Kontopidou F., Karkantaris C., Kokoris S., Giannakakis A., Barbounis A., Konstantopoulos K., Variamis E.,Rombos J.,Anargyrou K., Boutsis D.,Boussiotis V.A., Fessas Ph., Kittas C., Pangalis G.A. “ Prediction of bone marrow involvement on the basis of the clinical and laboratory characteristics of patients with Hodgkin’s lymphoma”. 8^th International Conference on Malignant Lymphoma, Lugano, Switzerland, 12-15 June, 2002.

   
   

2. Vassilakopoulos T., Angelopoulou M., Siakantaris M., Dimopoulou M., Korkolopoulou P., Kontopidou F., Karkantaris C., Kokoris ., Giannakakis A., Barbounis A., Konstantopoulos K.,Variamis E.,Rombos J., Anargyrou K., Boutsis D., Boussiotis V.A. Fessas Ph., Kittas C., Pangalis G.A. “Prediction of bone marrow involvement on the basis of the clinical and laboratory characteristics of patients with Hodgkin’s lymphoma”. 7^th meeting of the EHA, Florence, Italy, 6-9 June, 2002.

   
   

3. Kalotychou V., Janetea P., Boutsis D., Rombos J. “The cytoprotective role of amifostine to the normal stem cells against the toxicity of idarubicin”. 12^th Greek Haematology Conference, Athens, 22-24 November, 2001.

   
   

4. Politou M., Stamatopoulos K., Boutsis D., Komninaka V., Dimopoulou M., Viniou N., Plata E., Variamis E., Rombos J., Konstantopoulos K., Giataganas X. “Early experience of STI 571 use in patients with CML”. 12^th Greek Haematology Conference, Athens 22-24 November, 2001.

   
   

5. Rombos J., Boutsis D., Kalotychou V., Tsekoura C., Siakantaris M., Nodaros K., Anargyrou K., Poziopoulos C., Dimopoulou M., Vassilakopoulos T., Politou M., Variamis E., Pangalis G.A., Loukopoulos D. “Autologous Bone Marrow Transplantation in Lymphoma”. 12^th Greek Haematology Conference, Athens 22-24 November, 2001.